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1. Introduction 
Chlamydia trachomatis (C. trachomatis) is an obligate intracellular bacterium that causes 
significant human disease (Everett, Bush et al. 1999). This pathogen is usually categorized by 
its major outer membrane protein (MOMP) antigen, and serovars D though K infect the 
mucosal columnar epithelial cells of the urogenital tract (Linhares and Witkin 2010). Though 
C. trachomatis infection can be treated using several antibiotic regimens, the World Health 
Organization considers it to be the world’s most common bacterial sexually transmitted 
disease, infecting approximately 90 million people worldwide (Gerbase, Rowley et al. 1998). 
In 2010, the Center for Disease Control reported the rate of chlamydial infection in women 
as 592.2 cases per 100,000 in the US. In contrast, only 219.3 cases per 100,000 men were 
reported(CDC 2010). Clearly there remains an urgent need for improved risk assessment 
tools, disease prevention strategies, reliable screening regimens and efficacious treatments if 
we are to control this highly prevalent disease.  
Clinical presentation and disease sequelae after sexual transmission of C. trachomatis 
(serovars D-K) differ between men and women. In men, C. trachomatis infection is most 
typically symptomatic, is a common cause for urethritis and the much rarer syndrome of 
epididymitis(Peipert 2003), and is occasionally associated with impaired fertility(Idahl, 
Abramsson et al. 2007; Joki-Korpela, Sahrakorpi et al. 2009). C. trachomatis most commonly 
infects the endocervix in women, but the great majority (70-90%) of cases are 
asymptomatic(Peipert 2003). Natural history studies indicate individuals can spontaneously 
clear C. trachomatis infection, but this can take several months to several years(Dean, 
Suchland et al. 2000). Importantly, infection in women may be complicated by ascending 
infection and endometritis and/or salpingitis {reviewed in (Brunham and Rey-Ladino 
2005)}. Pelvic inflammatory disease (PID) is a too frequent end result of chlamydial infection 
of the female lower genital tract. While the final syndrome is most certainly multibacterial, 
Neisseria gonorrheae and C. trachomatis are frequent inciting factors (Paavonen and Lehtinen 
1996). PID is an ascending genital infection from the cervix to the upper genital tract with 
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infectious spill into the female peritoneal cavity. The disease can result in scarring and 
pelvic organ disfigurement that lead to increases in ectopic pregnancy rates, tubal factor 
infertility (Hellstrom, Schachter et al. 1987) and possibly early pregnancy wastage (Witkin 
1999). If left untreated during pregnancy, chlamydial genital infections in women have been 
associated with preterm delivery (Rours, Duijts et al. 2011).  
2. Developmental cycle of Chlamydia trachomatis 
Chlamydia exhibits a predominantly biphasic developmental cycle, differentiating between a 
metabolically inactive but infectious elementary body (EB) and a replicating and 
metabolically active, but non-infectious, reticulate body (RB) (Nelson, Virok et al. 2005; 
Linhares and Witkin 2010). Attachment and entry of EBs into permissive cells are critical 
steps in chlamydial development, but the molecules and mechanisms utilized in these 
processes are not well understood. Several bacterial ligands have been implicated as 
adhesins, and include heparin sulfate-like proteins, MOMP, OmcB, glycoproteins and 
Hsp70 (reviewed by Hackstadt 1999). The host factor/s involved in attachment is/are likely 
proteinacious, and the host cytoplasmic chaperone protein disulfide isomerase (PDI) has 
been strongly implicated as a structural requirement for attachment of multiple serovars, as 
well as necessary for entry (Davis, Raulston et al. 2002; Conant and Stephens 2007; 
Abromaitis and Stephens 2009). After EB internalization, Chlamydia-derived vesicles mature 
into a specialized parasitophorous vacuole termed an inclusion, which is nonfusogenic with 
lysosomal and endosomal membranes (Fields, Fischer et al. 2002; Carabeo, Mead et al. 2003; 
Hybiske and Stephens 2007a; Hybiske and Stephens 2007b). The exact mechanisms involved 
in the differentiation of the chlamydial EB into a RB remain incompletely described, but 
morphological investigations have demonstrated decondensation of chromatin occurs early 
in the process and supports the transition from a metabolically inert EB to a metabolically 
active RB (Beatty, Byrne, et al. 1993; Beatty, Morrison, et al. 1995; Belland, Zhong et al. 2003)  
Elegant investigations using transcriptional profiling have listed chaperonin, metabolite 
translocation, metabolite interconversion, endosomal trafficking, and inclusion membrane 
modification genes to be among the first to be activated (immediate early genes) during this 
transition (Belland, Zhong, et al. 2003; AbdelRahman and Belland 2005). As might have been 
predicted, these genes fall into categories required for pathogen acquisition of nutrients and 
for inhibiting fusion of the chlamydial inclusion with the host cell lysosomal pathway. 
Inside the inclusion, the elementary bodies differentiate into reticulate bodies that, in turn, 
divide rapidly via binary fission. RB condense back into EB and completion of the 
chlamydial cell cycle results in EB release by host cell lysis or extrusion (Todd and Caldwell 
1985; ; Hybiske and Stephens 2007b). Secondary differentiation of RB back into EB involves 
late gene expression and includes genes that direct recondensation of chromosomes, 
production of the outer membrane complex and even a number of genes previously 
described as immediate early genes (Nicholson, Olinger et al. 2003; AbdelRahman and 
Belland 2005). This latter finding appears to suggest that the EB is readying itself for its next 
cycle of attack. Newly-released, re-differentiated EB are thence able to infect nearby 
epithelial cells.  
3. Chlamydial persistence 
The term “persistence” has been used to describe an alternative in vitro pattern of 
chlamydial growth during which the bacteria cannot be cultivated, but remain viable for 
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extended periods of time (Beatty, Belanger et al. 1994; Belland, Nelson et al. 2003). 
Persistence is characterized by the presence of large, morphologically aberrant RB within the 
inclusion (Beatty, Morrison et al. 1995). While the chlamydial chromosomes can continue to 
divide in these aberrant RB in vitro, replication by binary fission does not occur nor does re-
differentiation into EB (Beatty, Morrison et al. 1995). To date, there is no direct evidence that 
persistence occurs in vivo. That said, in vivo persistence is suggested by several clinical 
findings. Firstly investigators have shown that chlamydial antigens and nucleic acids can be 
detected in tissues that do not support cultivable growth (Holland, Hudson et al. 1992; 
Patton, Askienazy-Elbhar et al. 1994). Second, multiple, same-serovar recurrent C. 
trachomatis infections have been observed in a cohort of women over a 2-5 year period 
despite antibiotic treatment (Dean, Suchland et al. 2000) . Thirdly, gynecologic and primary 
care clinicians frequently encounter recurrent chlamydial disease when re-infection is highly 
unlikely (e.g., no longer sexually active; prior tubal ligation surgery) again suggesting long-
term dormancy of chlamydial forms. The induction of persistence has been implicated in 
chlamydial immune evasion and pathogenesis (Beatty, Byrne et al. 1993; Beatty, Byrne et al. 
1994; Beatty, Morrison et al. 1994). We hypothesize that the ability of C. trachomatis to enter 
into a persistent growth form in vivo might represent a balance between host and pathogen 
struck through many years of co-evolution. The fact that persistent chlamydial forms are 
non-infectious could limit their immune detection for extended periods of time, and thereby 
limit immune-mediated damage. The fact that persistent chlamydial forms can be rapidly 
induced to return to the typical developmental cycle with removal of growth stressors in 
vitro (Beatty, Morrison et al. 1995; Belland, Nelson et al. 2003) would also suggest bacteria 
could successfully survive what might otherwise be lethal exogenous or host-induced 
stressors.  
A variety of stressors can cause C. trachomatis to enter into persistent growth in vitro. These 
include exposure to antibiotics such as penicillin and ampicillin, interferon gamma (IFN) 
and nutrient depletion (Clark, Schatzki et al. 1982; Beatty, Byrne et al. 1993; Belland, Nelson 
et al. 2003; Wyrick 2010). While most in vitro persistence models are in transformed cell 
lines, persistent chlamydial forms have recently been induced in primary human 
endocervical epithelial cell cultures using ampicillin  (Wang, Frohlich et al. 2011). While 
ampicillin and penicillin are not used in treatment of chlamydial infections, it has been 
noted that the widespread use of these antibiotics for control of other infections could 
inadvertently encourage the development of persistent forms in infected, undiagnosed 
individuals (Wyrick 2010). It is also a possibility that improper dosage and exposure 
duration of appropriate antibiotics for treatment of C. trachomatis may divert chlamydial 
organisms into the persistence pathway; indeed the presence of morphologic variants of C. 
trachomatis has been documented in the genital tissues of a small proportion of men and 
women treated with azithromycin (Bragina, Gomberg et al. 2001).  
Cytokines secreted by local phagocytes, NK cells and T cells are important in immune 
defense against infection. These same cytokines, however, may also be implicated in disease 
pathogenesis. For many pathogens, including C. trachomatis, IFN plays an important role in 
resolution of infection (Marks, Tam et al. 2010; Agrawal, Bhengraj et al. 2011; Matthews, 
Wilkinson et al. 2011; Ohman, Tiitinen et al. 2011; Patel, Stefanidou et al. 2011). The role of 
IFN in chlamydial clearance is complicated by the fact that inflammation can damage host 
cells and IFN itself can also drive persistence (Beatty, Belanger et al. 1994). IFNexposure 
induces the expression of indoleamine 2,3-dioxygenase (IDO) in various types of epithelial 
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cells (Feng and Taylor 1989). The IFN-mediated induction of IDO facilitates the 
catabolism of tryptophan to kynurenine (Beatty, Belanger et al. 1994). C. trachomatis is a 
tryptophan auxotroph, and continuous exposure to IFNat inhibitory concentrations 
results in the eradication of the bacteria (Byrne and Krueger, 1983). However, exposure to 
sub-inhibitory IFNconcentrations, which may be a likely scenario in vivo, induces 
chlamydial organisms to enter a persistent phase, with characteristic aberrant inclusions 
and the presence of small, non-replicating RB (Byrne and Krueger 1983). A potential 
therapeutic problem associated with IFN-induced persistence is the reduced bactericidal 
activity of doxycycline against these aberrant growth forms as demonstrated by Reveneau 
et al., in vitro (Reveneau, Crane et al. 2005). We (Ibana, Nagamatsu et al. 2011) have 
recently demonstrated that levo-methyl-tryptophan (L-1MT), an IDO inhibitor, prevents 
IFN┛-induced C. trachomatis persistence without resulting in productive multiplication of 
the bacterium. L-1MT also improved the efficacy of doxycycline against the IFN-induced 
C. trachomatis persistent forms, and may thus provide a novel approach to clear 
doxycycline-resistant forms of the bacterium. 
Although persistence has not been definitively demonstrated in vivo, in vitro modeling has 
suggested a role for persistent chlamydial forms in disease pathogenesis. While synthesis of 
many of the antigenic outer membrane antigens is decreased in in vitro persistence models 
(Beatty, Morrison et al. 1995), persistent organisms do replicate their chromosomal material 
and they remain metabolically active (Belland, Nelson et al. 2003). In fact, persistent 
organisms induced by IFN and penicillin exposure continue to produce and secrete the 60 
kDa chlamydial heat shock protein, CHSP60 (Beatty, Byrne et al. 1993; Beatty, Morrison et 
al. 1995; Linhares and Witkin 2010). Although circulating antibodies against C. trachomatis 
membrane associated proteins (MOMPs) have been linked to infertility, the presence of anti-
CHSP60 antibodies appears to be more sensitive and specific for the disease (Linhares and 
Witkin 2010; Stephens, Aubuchon et al. 2011). The presence of  anti-CHSP60 IgA antibodies 
in the cervical secretions of women undergoing IVF has been associated with decreased live 
birth rates (Witkin 1999) and the presence of circulating IgG to CHSP60 in women with 
prior ectopic pregnancy has been linked repeat ectopic pregnancy and other adverse 
pregnancy outcomes (Sziller, Fedorcsak, et al 2008). To explain these findings, it has been 
hypothesized that prolonged exposure to CHSP60 may break tolerance to the human HSP60 
that is normally expressed by normal human embryos (Linhares and Witkin 2010, Stephens, 
Aubuchon et al. 2011).  
4. Pathogen immune evasion 
Millions of years of co-evolution have benefitted many pathogens and their hosts. 
Constantly changing pathogenic challenges allowed hosts to develop efficient, effective, 
redundant and advanced immune systems. The evolving host has driven the successful 
pathogen to develop strategies to evade detection by the host immune systems. At times, 
immune detection is evaded just long enough to enable a complete pathogen replication 
cycle with spread of progeny to surrounding cells. For other pathogens, immune evasion 
allows for prolonged and even lifelong pathogen persistence. 
Exogenous pathogens, whether they are viral or bacterial, typically encounter several 
barriers to infection and successful pathogens have adapted to breech these barriers. For 
most pathogens, the first of these obstacles involves surviving in a local mucosal 
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Immune 
Effector Cell 
Type  
Host Cell 
Ligand  
Immune Cell 
Ligand  
Function of  
Mucosal Immune 
Cell 
Mechanism of 
Pathogen 
Recognition 
C. Trachomatis 
Evasion Strategy 
CD8+ T cell 
recognition 
(adaptive 
immunity)  
MHC class I T cell receptor Response to 
altered self  or to 
cytosolic, 
pathogen -
derived antigens 
IDO induces 
IFN┛-mediated 
increases in host 
MHC class I 
expression at 
the cell surface 
CPAF-mediated 
degradation of 
RFX-5, which is 
essential for 
IFN┛-induced  
MHC class I 
expression  
Amino-terminal 
CPAF fragment 
(CPAFn) directly 
involved  
CD4+ T cell 
recognition 
(adaptive 
immunity)  
MHC class II T cell receptor Response to 
extracellular/ 
endosomal  
pathogens 
IFN┛ increases 
MHC class II 
(HLA-DR) 
expression 
on infected host 
cells  
CPAF-mediated 
degradation of 
USF1, a 
transcription 
factor important 
for MHC class II 
expression.  
Carboxy-
terminal 
fragment  
(CPAFc) directly 
involved  
Natural Killer 
Cell 
recognition 
(innate 
immunity)  
MHC class I
(non-antigen 
dependent)  
Killer 
inhibitory 
receptors 
(KIRs; 
inhibitory) 
NKG2D  
(activating) 
others  
Self/non-self 
recognition; 
Absence of self 
signals 
abnormality 
Innate immunity 
Altered 
expression of 
self MHC class I 
recognized by 
NK expressed 
inhibitory KIRs
Altered 
expression of 
MICA 
recognized by 
NK cell 
expressed 
activating 
NKG2D 
MICA 
expression 
altered only in 
directly-infected 
cells  
Natural Killer 
T cells (innate 
immunity)  
CD1d V24-JQ/V11
Invariant T cell 
receptor 
Response to lipid-
derived antigens. 
CD1d molecule 
recognizes NKT 
cell receptor  
and  produces  
IFN┛. 
IFN catabolizes 
tryptophan and 
aids in clearing 
C. trachomatis 
infection  
CPAF and 
cellular 
proteasome –
mediated 
degradation of  
host MHC class I 
and CD1d  
surface 
expression 
CPAF binds 
directly to the 
CD1d 
cytoplasmic tail  
Table 1. MHC and MHC-like ligands modulated by C. trachomatis to evade immune detection 
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microenvironment and crossing the mucosal epithelial barrier. The common gastrointestinal 
bacterium, Heliobacter pylori, is particularly adept at this. H. pylori express a variety of 
colonization factors, including outer membrane adhesins, which allow the bacteria to 
survive in the acidic and mucus-filled gastrointestinal lumen and attach to epithelial cell 
surfaces (Fischer, Prassl et al. 2009). Once the epithelial barrier has been breached, 
pathogens must next surmount innate immune detection. Such detection includes 
recognition by the host complement system and by host macrophages, dendritic cells, 
monocytes, neutrophils and eosinophils (Ploegh 1998). The latter includes recognition 
through, among others, Toll-like receptors (TLRs), nucleotide-binding and oligomerization 
domain (NOD)-like receptors and helicases (Xiao 2010). Several bacteria, including 
Salmonella enterica, Escherichia coli and several Brucella species use molecular mimicry to 
evade host immune signaling and the innate immune recognition and clearance mediated 
by these cell surface receptors (Xiao 2010). Successful pathogens must next subvert, at least 
temporarily, those immune cells that straddle innate and adaptive immune functionality, 
including natural killer (NK) and natural killer T (NKT) cells (Table 1, Figure 1). Finally 
pathogens that have survived the previous obstacles will encounter the host adaptive 
immune response involving B and T cells and both immediate and memory responses. 
Intracellular pathogens, including most viruses, have developed a wide variety of immune 
evasion strategies. For example the human herpesviruses are characterized by their ability to 
establish latency in immunocompetent human hosts, often with infrequent or absent 
symptomatology. These DNA viruses comprise a large group of related pathogens with 
well-described but variable mechanisms for abrogating presentation of virus-derived 
antigens to host immune cells via major histocompatibility (MHC) class I molecules 
(Tortorella, Gewurz et al. 2000; Horst, Ressing et al. 2011). Extracellular pathogens are more 
likely to target antigen presentation by MHC class II molecules. 
Historically, it was thought that chlamydial antigens were retained within the inclusion. 
More recent studies, however, have reported that both CD4+ and CD8+ T cells respond to 
chlamydial-derived antigens (Grotenbreg, Roan et al. 2008; Roan and Starnbach 2008; Finco, 
Frigimelica et al. 2011) suggesting that MHC class I and MHC class II antigen presentation 
are both involved in chlamydial recognition and that antigen cross-presentation or 
autophagy could be important in chlamydial clearance and possibly in chlamydial 
pathogenesis (Finco, Frigimelica et al 2011). We now know that chlamydial antigens access 
the host cell cytosol through a variety of mechanisms (Cocchiaro and Valdivia 2009). Wyrick 
et al. have shown in an elegant series of experiments that chlamydial antigens are present in 
the cytosol attached to vesicles that have everted from the C. trachomatis inclusion (Giles, 
Whittimore et al. 2006) and that C. trachomatis antigens can traffic to the endoplasmic 
reticulum (ER) of infected epithelial cells (Giles and Wyrick 2008). Interestingly, some of the 
chlamydial antigens that trafficked to the ER were seen to co-localize with the MHC-like 
molecule CD1d (see below) (Wyrick 2010). Others have shown that proteins such as the 
chlamydial outer membrane complex protein B (OmcB) (Qi, Gong et al. 2011) and the 
chlamydia protease, CPAF (see below), are present in the host cell cytosol (Sharma, Bosnic et 
al. 2004; Kawana, Quayle et al. 2007), the latter being secreted through a Sec-dependent 
pathway (Chen, Lei et al. 2010). C. trachomatis also uses the type III secretory system (T3SS) 
to move bacterial virulence proteins from EB into the host cytosol (Clifton, Fields et al. 2004; 
Hower, Wolf et al. 2009). Not surprisingly, C. trachomatis has devised immune evasion 
strategies to subvert host recognition of infection via MHC class I and MHC class II. While 
several additional mechanisms for pathogen evasion of host clearance have been reported 
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(Betts, Wolf et al. 2009), we will concentrate here on C. trachomatis immune evasion via 
modulation of those surface-expressed ligands important in antigen presentation. 
5. Downregulation of MHC class I and II  
Chlamydial avoidance of adaptive immune responses involving CD8+ T cells and CD4+ T 
cell recognition (Van Voorhis, Barrett et al. 1996; Kelly, Walker et al. 2000; Rank, Bowlin et 
al. 2000) can involve pathogen-driven suppression of host cell surface expression of IFN┛-
inducible MHC class I and II molecules at the site of infection (Fruh, Ahn et al. 1997). The 
major histocompatibility complex (MHC) is a polymorphic and polygenic host DNA region 
used by cells to produce and present 8-10 amino acid, self- and pathogen-derived peptides 
at the host cell surface. Altered self peptides (e.g., from neoplastic change) and pathogen-
derived peptides are antigenic and induce host immune response. The two most prominent 
products encoded by the MHC in humans are referred to as MHC class I and class II 
molecules (Figure 1). Each provides information to the host immune system on antigenic 
insults, although these insults conventionally differ in location. MHC class I molecules bind 
and present peptides at the host cell surface that are derived from altered self or from 
intracellular pathogens (typically within the host cytosol). In contrast, MHC class II 
molecules bind and present peptides from extracellular pathogens, whose destruction and 
processing typically occurs within the host cell endosome (Germain 1986). This relative 
dichotomy is challenged by the classical description of inclusion-sequestered chlamydia-
derived antigens. As discussed above, there are many descriptions of cytosolic and 
extracellular  (Campbell, Larsen et al. 1998) chlamydial antigens that now explain the 
detection of CD4+ and CD8+ T cell responses to chlamydial antigens (Figure 1). 
The expression of MHC class I molecules on epithelial cells is up-regulated by IFN┛ during 
most infections (Maudsley and Morris 1989). RFX, a transcription complex that binds to the 
promoter region of MHC class I and class II molecules is important for both constitutive and 
IFN┛-inducible MHC class I expression in chlamydia infected cells (van den Elsen and 
Gobin 1999). Zhong, et al (Zhong, Liu et al. 2000) were the first to show that degradation of 
RFX5 occurred in cells infected with C. trachomatis L serovars and that such degradation 
inhibited both constitutive and IFN┛-inducible MHC class I expression in infected cells. As 
predicted, cells from patients deficient in RFX 5, a sub-unit of RFX, exhibit reduced IFN┛-
mediated induction of MHC class I expression (Gobin, Peijnenburg et al. 1998).  
Chlamydia has also evolved a strategy for inhibiting IFN┛-inducible MHC class II 
expression. Here the pathogen degrades a ubiquitously expressed transcription factor 
required for IFN┛-mediated induction of the MHC Class II trans-activator (CIITA), called 
upstream stimulatory factor 1 (USF1) (Zhong, Fan et al. 1999). USF1 is a non-DNA-binding 
co-activator required for MHC class II expression (Chang, Fontes et al. 1994). A more 
detailed mechanism for this degradation was put forth with the discovery of its more 
generalized role in MHC degradation and is now known to involve a chlamydia-encoded 
proteasome-like activity factor (CPAF). CPAF is present in the cytosol of chlamydia-infected 
cells and is primarily responsible for the degradation of RFX5 and USF1 and subsequent 
down regulation of surface MHC class I and II expression, respectively. The active 
components of CPAF are a dimer consisting of a 29kDa amino-terminal fragment (CPAFn) 
and a 35KDa carboxy-terminal fragment (CPAFc). Activity of the CPAFn fragment has been 
shown to be responsible for degradation of RFX5  (Zhong, Fan et al. 2001). With the very 
recent description of a specific inhibitor of CPAF (Bednar, Jorgensen et al. 2011) it is  
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Fig. 1. Presentation of chlamydial antigens. Cytosolic antigens are degraded by the cellular 
proteasome into 8-10 amino acid peptide fragments that are actively transported into the 
lumen of the endoplasmic reticulum (ER). These antigenic peptides (depicted as short black 
lines) are loaded into the peptide binding groove of the MHC class I heavy chain. Heavy 
chains containing peptide associate with an invariant chain, 2-microglobulin, and are 
processed thru the Golgi apparatus for stable expression at the host cell surface. Here, MHC 
class I molecules interact with T cell receptors (TCRs) on CD8+ T cells or with 
immunoglobulin-like killer inhibitory receptors (antigen independent) on natural killer 
(NK) cells (antigen dependent). The MHC class I-related protein A (MICA) is also processed 
through the secretory pathway for type-2 proteins, but is expressed at the cell surface in the 
absence of 2-microglobulin or antigenic peptide. Here MICA can bind to activating 
receptors on the NK cell (antigen independent). Lipid-derived antigens are presented on the 
cell surface by the MHC-like molecule, CD1d which is also stably expressed as a trimer of 
heavy chain, 2-microglobulin and antigen. CD1d presents antigen to natural killer T (NKT) 
cells bearing an invariant V24-JQ/V11 TCR. Extracellular antigens bind to MHC class II 
molecules for presentation at the cell surface. The MHC class II molecule is processed thru the 
secretory pathway for direct expression at the cells surface or for transfer into the endocytic 
pathway. Extracellular peptides can enter the MHC class II antigen-binding groove on cell-
surface-expressed MHC class II directly or after displacement from other cell surface antigen-
presenting molecules. More commonly, antigen loading of MHC class II occurs within the 
endocytic pathway. Although chlamydiae actively prevent fusion of their intracellular 
inclusions with the endocytic pathway, CD4+ T cells do respond to chlamydial antigens.  
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expected that much more will be learned about CPAF and about chlamydial pathogenesis 
and prevention in the coming years.  
6. Production of CPAF and effects on CD1d 
CPAF also interacts with the antigen presenting molecule, CD1d (Skold and Behar 2003). 
CD1d is similar in structure to MHC class I molecules. Like MHC class I and class II 
molecules, CD1 can present peptide antigens, although these peptides are typically quite 
hydrophobic (Boes, Stoppelenburg et al. 2009). Unlike MHC products, CD1d is monogenic 
and has fairly limited polymorphism. CD1d most commonly presents lipid-derived antigens 
from self- and pathogen-derived sources to natural killer T (NKT) cells (Porcelli 1995). CD1d 
molecules recognize an invariant V┙24-JQ/V┚11 T cell receptor expressed by human NKT 
cells (Porcelli, Gerdes et al. 1996; Zhou 2007). CD1d recognition by invariant NKT cells 
results in the production of large amounts of both IL-4 and IFN┛ by the NKT cell that is 
suggested to play a role in TH1/TH2 differentiation of CD4+ T helper cells. (Taniguchi and 
Nakayama 2000). Using an immortalized penile urethra-derived epithelial cell line 
developed in our laboratory, we have demonstrated that C. trachomatis infection decreases 
cell surface expression of CD1d (Figure 2) (Kawana, Quayle et al. 2007). This effect was  
 
Fig. 2. Putative proteolytic degradation pathways for CD1d HCs upon C. trachomatis 
infection. In C. trachomatis-infected cells, 2m-unassembled CD1d HC forms accumulate in 
the ER due to degradation of RFX5 by CPAF. CPAF secreted from the chlamydial inclusion 
into the cytosol interacts with the CD1d HC via the cytoplasmic tail of CD1d and CPAF is 
ubiquitinated. The binding of CPAF triggers dislocation of the 45-kDa immature 
glycosylated form of CD1d into the cytosol. One proteolytic pathway involves the 
conventional cellular proteasome. Glycosylated CD1d HC is ubiquitinated in the cytosol 
(ubiquitin ligase), and deglycosylated (peptide N-glycosidase) to create the 37-kDa , non-
glycosylated CD1d molecule. CPAF and the ubiquitinated, deglycosylated CD1d HC are 
degraded by the cytosolic proteasome. The alternative proteolytic pathway involves CPAF-
mediated degradation. The 45-kDa immature glycosylated CD1d HC interacts with CPAF. 
CPAF targets the CD1d HC for degradation  by a proteolytic activity distinct from that of 
the cytosolic proteasome. Green symbols indicate multiubiquitins. Kawana, et. al., J Biol 
Chem 2001; 282(10): 7368-7375. Reproduced with permission. 
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again linked to the proteasomal activity of CPAF. CPAF binds to the cytoplasmic tail of the 
nascent CD1d heavy chain and targets it for degradation by a CPAF-mediated pathway and 
via a pathway that includes the ubiquitination and deglycosylation steps integral to the 
conventional unfolded protein response (Kawana, Quayle et al. 2007). The immunoevasive 
targeting of CD1d is not unique to C. trachomatis. We have also shown that cell surface 
expression of CD1d is reduced in vitro and in vivo in human papillomavirus (HPV)-positive 
cells (Miura, Kawana et al. 2010). This effect can be isolated to the presence of the E5 
proteins of HPV subtype 6 and HPV subtype 16, it occurs at a post-transcriptional level and 
it is mediated by proteasomal degradation. 
In addition to known expression on standard antigen-presenting cells, CD1d is found on 
alternative APCs, including intestinal epithelial cells (Blumberg, Terhorst et al. 1991),  
epidermal keratinocytes (Bonish, Jullien et al. 2000) and basal and suprabasal cells of the  
vaginal, ectocervical, and penile urethral epithelia (Kawana, Matsumoto et al. 2008). In 
contrast, limited expression of CD1d was seen in human endocervical and endometrial 
tissues, the former representing the major cellular target for C. trachomatis in the female 
genital tract. In vitro exposure of genital tract cells to IFN increased cell surface 
expression of CD1d in all cells studied, although the strongest induction was seen in those 
cells that expressed CD1d at the highest levels in vivo. Through these studies, Kawana, et. 
al. (Kawana, Matsumoto et al. 2008) were the first to place a functional significance on C. 
trachomatis-mediated reductions in cell surface expression of CD1d. Antibody-induced 
cross-linking of CD1d on penile urethral epithelial cells induces the secretion of IL-12 and 
IL-15. Cross-linking induced Th1 cytokine production was abrogated in penile urethral 
cells infected with C. trachomatis (Kawana, Matsumoto et al. 2008). A relative deficiency in 
CD1d baseline expression in the human endocervix and poor IFN-induced CD1d 
expression in penile urethral cells may make these sites particularly susceptible to 
pathogen transmission.  
7. Effects of C. trachomatis on surface ligand expression in directly-infected 
and bystander cells 
Although we and others had previously reported on C. trachomatis-mediated inhibition of 
IFN┛-inducible MHC class I and II expression and Cd1d expression (Zhong, Fan et al. 1999; 
Zhong, Liu et al. 2000; Zhong, Fan et al. 2001; Kawana, Quayle et al. 2007; Kawana, 
Matsumoto et al. 2008), all published experiments had been conducted via bulk analysis of 
mixed populations of infected cells and non-infected bystander cells. Transmission of C. 
trachomatis to the epithelial cells in the genital tract after in vivo exposure likely results in 
only a small population of infected cells. Some in vitro protocols exist that can result in 
infection of a very high proportion of C. trachomatis-infected epithelial cells, but this does not 
reflect in vivo infection characteristics. Other infection protocols used for in vitro study of 
host immune response to C. trachomatis infection result in a mixed population of C. 
trachomatis-exposed cells and uninfected, bystander cells. Bulk analysis of these mixed 
populations, however, dilutes changes that may occur in only one of these subpopulations. 
We hypothesized that separation of these cellular subpopulations, when combined with 
side-by-side analyses, would allow a more inclusive and accurate assessment of the overall 
impact of C. trachomatis on host epithelial cell immune response.  
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We have recently completed and published our first investigation on C. trachomatis immune 
evasion strategies that stratified cells by infection status to allow independent  assessment of 
immune cell ligands on infected and uninfected host epithelial cells in a single culture 
(Ibana, Schust et al. 2011). Using flow cytometry to separate C. trachomatis-infected cells 
from those non-infected bystander cells, we were able to investigate the possible indirect 
effects of soluble factors released during C. trachomatis infection on uninfected cells. We 
hypothesized that investigating the effects of C. trachomatis in both infected and uninfected 
bystander cells would promote a better understanding of the immunological milieu induced 
by C. trachomatis at the local site of infection and concentrated our initial efforts on the MHC 
class I molecule.  
Natural killer (NK) cells and CD8+ T cells are important components of the host cellular 
immune defense against intracellular microorganisms (Figure 1). Each of these immune cell 
subpopulations can mediate their protective immune activities via two mechanisms: (1) 
direct cytolysis and (2) secretion of IFNand other cytokines [reviewed in (Trinchieri 1989). 
Direct cytolytic activities are induced by the interaction of cell surface receptors on NK cells 
and CD8+ T cells with the ligands expressed on the surface of target cells. CD8+ T cells can 
lyse target cells that express cognate antigens presented by the target cell MHC class I 
molecule. The immunologic activity of NK cells results from a summation of signals 
mediated through NK cell-expressed activating and inhibitory receptors (Moretta et al. 
2001). Unlike those of CD8+ T cells, NK cell ligand-mediated interactions are typically 
antigen-independent. While MHC class I products bind to an inhibitory class of NK cell 
killer immunoglobulin-like receptors (KIRs) to aid in self/non-self recognition, other ligands 
on host cells can bind to activating NK cell receptors. One such molecule, the target cell-
expressed MHC class I-related protein A (MICA), primarily functions as a ligand for the NK 
cell activating receptor, NKG2D (Bauer, Groh et al. 1999). It is well-documented that 
modulation of the expression of these ligands on host cells is one of the primary strategies 
that intracellular microorganisms use to evade immune cell recognition. Intracellular 
microorganisms that can diminish surface expression of MHC class I by their host cells are 
more impervious to CD8+ T cell activity. However, the loss of MHC class I at the cell surface 
may make the infected host cells more susceptible to cytolytic NK cell activity when the 
interacting NK cell expresses a predominance of activating NK cell receptors (Ljunggren 
and Karre 1990) In short, co-evolution alongside human pathogens may have driven the 
development of host NK cells to counter the ability of some intracellular pathogens to evade 
immune detection via downregulation of host MHC class I expression. 
By examining directly-infected and uninfected bystander cells separately, we have shown 
that MHC class I downregulation in the presence of C. trachomatis is mediated by direct and 
indirect (soluble) factors (Ibana, Schust et al. 2011) In contrast, we now have preliminary 
data suggesting that MICA expression is altered in C. trachomatis-infected cells but not in 
bystander, uninfected cells (Ibana, Aiyar et al. 2012). C. trachomatis infection of epithelial 
cells alters two well-documented characteristics of infected cultures: (a) their immune cells 
ligand expression (Soderlund and Kihlstrom 1982; Zhong, Fan et al. 1999; Zhong, Liu et al. 
2000; Kawana, Quayle et al. 2007; Ibana, Nagamatsu et al. 2011)  and (b) the extent and 
nature of epithelial cell chemokine and cytokine secretion (Rasmussen, Eckmann et al. 1997). 
Changes in the cell surface expression of immune cell ligands on epithelial cells at the local 
site of C. trachomatis infection may reflect the susceptibility of these cells to host immune cell 
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mediated activities, while the secretion of soluble factors can facilitate the migration of host 
immune cells to the infected site. We hypothesize that these soluble factors may play an 
important role in the cross-talk between C. trachomatis-infected cells and neighboring 
uninfected cells. We are presently in the process of further defining the host soluble factor or 
factors that may be responsible for the decrease in MHC class I surface expression on 
uninfected-bystander cells in C. trachomatis serovar D-infected endocervical epithelial cell 
(A2EN) cultures, and suspect there may be several factors involved.  
8. MHC class I expression after infection with genital and disseminating  
C. trachomatis serovars 
As a corollary to these observations, we find it intriguing to comment on reports showing 
that a lymphogranuloma venereum (LGV) serovar of C. trachomatis, which causes a 
disseminated form of infection, utilizes CPAF to downregulate both constitutive and IFN-
induced MHC class I expression in cervical epithelial (HeLa) cells (Zhong, Liu et al. 2000; 
Zhong, Fan et al. 2001). This finding was interpreted by the investigators to represent an 
important mechanism for immune evasion of CD8+ T cell recognition by C. trachomatis. We 
have confirmed the LGV modulation of MHC class I in our own experiments (Figure 3) 
However, using C. trachomatis serovar D, which  causes local infection within the female 
genital tract, we have seen that the level of MHC class I down regulation is less than after 
serovar LGV infection and that IFN attenuates the down-modulation of MHC class I 
expression in C. trachomatis-infected cells and in bystander, uninfected cells (Ibana, Schust et 
al. 2011). Rather, MHC class I expression in IFN-exposed cells remains similar to that in 
mock-infected controls (Figure 3).  
 
Fig. 3. MHC class I modulation after exposure to non-disseminating (serovar D) and 
disseminating (serovar L2) genital C. trachomatis. Primary-like endocervical epithelial cells 
(A2EN) were infected with C. trachomatis serovar L2 or serovar D. Surface MHC class I 
expression was quantitated in chlamydial-LPS-positive cells gated by flow cytometry. A 
dramatic decrease in the surface expression of MHC class I was observed in A2EN cells 
infected with serovar L2 at 34 hours post infection (hpi); those infected with serovar D 
exhibited much smaller decreases in MHC class I expression. Although the IFN-induced 
increase in MHC class I was noted in both infected and uninfected cells, it was attenuated 
with C. trachomatis serovar D infection.  
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These results may suggest that genital C. trachomatis serovars do not utilize evasion of CD8+ 
T cell recognition via MHC class I modulation to the extent that disseminating serovars do. 
Supporting our observations are reports that chlamydia-specific CD8+ T cells are fully 
capable of lysing epithelial cells infected with genital serovars of C. trachomatis (Roan and 
Starnbach 2006; Grotenbreg, Roan et al. 2008). Others have noted differences in vitro in the 
innate immune responses to genital C. trachomatis serovar E and disseminating C. trachomatis 
serovar L2 infection of HeLa cells (Dessus-Babus, Knight et al. 2000). In vivo, the former 
results in local or ascending infection with canalicular spread along genital mucosal 
surfaces. In contrast, disseminating chlamydial disease is a sub-mucosal infection with rapid 
spread to regional lymph nodes (Schachter and Osoba 1983). In vitro, the release of the anti-
inflammatory cytokine IL-11 was increased in HeLa cells infected with C. trachomatis serovar 
L2 when compared to cells infected with the non-disseminating genital serovar E (Dessus-
Babus, Knight et al. 2000). Although the mechanism for differences in MHC class I 
modulation between the Serovar D- and LGV-infected cells remains unknown, this 
observation may also help to explain the localization of infection with genital C. trachomatis 
serovars but disseminated disease after infection by LGV serovars and certainly warrants 
further investigations. Since MHC class I down-regulation is linked to CPAF activity 
(Zhong, Liu et al. 2000; Zhong, Fan et al. 2001), this could be a protein of interest, as would 
other secreted chlamydial proteins.  
9. Conclusions 
Host-pathogen co-evolution drives adaptations in each partner that ensure survival of the 
host and propagation of the pathogen. This often involves sophisticated methods of injury 
evasion but neither the host nor the pathogen typically acquires complete protection. Rather, 
compromises are met that partially benefit both partners. For C. trachomatis and its human 
host, this balance could be typified by the concept of chlamydial persistence. Persistent 
growth in vitro is promoted by exogenous growth conditions that are stressful to the 
pathogen, but re-initiation of the productive growth cycle occurs when these stressors are 
removed. Although there is currently no direct human in vivo evidence for chlamydial 
persistence due to the very challenging nature of these types of investigations, we have 
postulated that this phenomenon may protect the host from relatively prolonged and/or 
intense immune-induced pathologies. On the other hand, chlamydial persistence may also 
provide a mechanism that enables the pathogen to establish prolonged infection and re-
infection even though this may be disadvantageous to some hosts over time. From this 
perspective, persistence may be perceived as an adaptation that may facilitate long-term 
association of pathogen and host.  
While a precarious balance must be struck between C. trachomatis and its host, we have here 
concentrated on several ways in which C. trachomatis evades host immune detection through 
modulation of surface ligands involved in antigen presentation. Since host response to 
chlamydial infections involves innate and adaptive immune cells, we have addressed 
mechanisms by which chlamydia can evade destruction by CD4+ and CD8+ T cells, as well 
as NK and NKT cells. We have reviewed data generated by ourselves and others on 
modulation of surface expression of MHC class I, MHC class II, CD1d and MICA. While the 
majority of these modulations appear to be advantageous only for the infecting pathogen, 
we have recently begun to look at direct and soluble mediators of these effects and their 
temporal initiation post-infection in an effort to better understand the host response to 
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immune evasion. Finally, we have begun to dissect serovar-specific differences in host cell 
surface ligand modulation as a means of gaining a more complete understanding of the 
pathogenesis of localized, ascending and disseminating infections with genital C. 
trachomatis. Continued study of host-pathogen interactions should help us to better address 
the epidemiology of C. trachomatis infection and to develop more effective disease treatment 
and prevention paradigms. 
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